Skip to main content

Investment Bank Upgrades Orchid BioSciences Stock; Shares Barely Budge

NEW YORK, July 29 (GenomeWeb News) - Caris & Company upgraded Orchid BioSciences' stock from 'above average' to 'buy' this morning.


News of the upgrade caused shares in Orchid to trade up 3.45 percent at $8.70 per share this afternoon.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.